In February 2021 Pfizer formed and agreement with CPI, becoming the newest partner of the Medicines Manufacturing Innovation Center—a collaboration between CPI, the University of Strathclyde and founding industry partners GSK and AstraZeneca, with funding provided by Scottish Enterprise and UK Research and Innovation. The center aims to advance emergent and disruptive technologies through a series of flagship “Grand Challenge” projects to increase productivity and patient outcomes in the pharmaceutical industry.

Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies. You can obtain detailed information about the use of cookies on our website by clicking on "More information”. Got It

Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.